Sun Pharma Advanced Research’s Q1 net loss down 83 percent

New Delhi, Aug 1 (IANS) Sun Pharma Advanced Research Company (SPARC) on Saturday reported a decline of 83 percent in its net loss for the first quarter of the current fiscal.

According to the company’s filing with the Bombay Stock Exchange (BSE), its net loss for the quarter under review stood at Rs.1.65 crore from a net loss of Rs.9.74 crore for the corresponding quarter of 2014-15.

The company’s total income increased by 17.11 percent during the first quarter of 2015-16 to Rs.43.65 crore from Rs.37.27 crore for the quarter ended June 30, 2014.

SPARC had de-linked from Sun Pharma as a research and drug discovery firm in 2007.

The company’s scrip at the Bombay Stock Exchange (BSE) had closed on Friday with gains of 1.01 percent or 4.10 points at Rs.408.80 from its previous close of Rs.404.70 per equity.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of or any employee thereof. is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here